C4 Therapeutics (CCCC) Return on Invested Capital (2020 - 2024)

C4 Therapeutics' Return on Invested Capital history runs 5 years deep, the most recent figure standing at 0.01% for Q4 2024.

• In Q4 2024, Return on Invested Capital changed 0.0% year-over-year to 0.01%; the TTM figure through Dec 2024 stood at 0.01% (changed 0.0% YoY), while the FY2025 annual figure was 0.0%, changed 0.0% from the prior year.
• Return on Invested Capital was 0.01% for Q4 2024 at C4 Therapeutics, down from 0.0% in the prior quarter.
• In the past five years, Return on Invested Capital ranged from a high of 0.0% in Q3 2020 to a low of 0.01% in Q4 2020.
• Historically, Return on Invested Capital has averaged 0.0% across 5 years, with a median of 0.0% in 2024.
• Biggest YoY gain for Return on Invested Capital was 0 bps in 2022; the steepest drop was 0 bps in 2022.
• A 5-year view of Return on Invested Capital shows it stood at 0.01% in 2020, then jumped by 72 bps to 0.0% in 2021, then decreased by 24 bps to 0.0% in 2022, then sank by 96 bps to 0.01% in 2023, then increased by 14 bps to 0.01% in 2024.
• The last three Return on Invested Capital figures came in at 0.01% (Q4 2024), 0.0% (Q3 2024), and 0.0% (Q2 2024), per Business Quant data.